+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
PAR

Par Drugs & Chemicals Share Price

 

 

Par Drugs & Chemicals live price: ₹87.81. It opened at ₹87 vs previous close ₹86; intraday high/low: ₹91/₹85. The 50 & 200 DMA stand at ₹89.65/₹99.18.

Par Drugs & Chemicals Performance

  • Today's Low
  • ₹85
  • Today's High
  • ₹91
  • 52 Week Low
  • ₹78
  • 52 Week High
  • ₹122
  • Open Price₹87
  • Previous Close₹86
  • Volume2,962
  • 50 DMA₹89.65
  • 100 DMA₹91.59
  • 200 DMA₹99.18

Par Drugs & Chemicals Chart

Investment Returns

  • Over 1 Month -6.66%
  • Over 3 Month -2.62%
  • Over 6 Month -10.1%
  • Over 1 Year -11.25%

Smart Investing Starts Here Start SIP with Par Drugs & Chemicals for Steady Growth!

Invest Now

Par Drugs & Chemicals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 8.2
  • PEG Ratio
  • -4.4
  • Market Cap Cr
  • 108
  • P/B Ratio
  • 1
  • Average True Range
  • 4.29
  • EPS
  • 10.65
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.62
  • RSI
  • 43.14
  • MFI
  • 54.56

Latest Stock News Updates

DDA removes separate parking charges from flat prices in housing schemes

In move that will provide relief to home buyers, the Delhi Development Authority has decided to remove separate parking charges from the total flat price in its housing schemes, officials said on Wednesday. According to a recent order, the Delhi Development Authority (DDA) has directed that the total cost of parking construction shall be included in the overall project expenditure. "No separate or additional cost on account of car garage, scooter garage and covered or uncovered parking shall be included in the total cost of the flat," the order states. The total cost of constructing parking spaces will now be included in the total expenditure incurred for the housing pockets to calculate the Plinth Area Rate (PAR) of flats, the order added. The order applies for all ongoing projects, including the DDA Karmayogi Awas Yojana 2025 (FCFS), DDA Towering Heights Karkardooma Housing Scheme 2025 (E-Auction), DDA Nagrik Awas Yojana 2026 (FCFS) and the DDA Towering Heights Karkardooma Housin

Lenders' MFI portfolio asset quality improves: MFIN

MFIN said MFIs' portfolio at risk or PAR level for 31-180 days buckets has improved to 4.1 per cent in Q2FY26 from 4.2 per cent in Q2FY25

Par Drugs & Chemicals Financials

Par Drugs & Chemicals Technicals

EMA & SMA

Current Price
₹87.81
+ 2.16 (2.52%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹88.47
  • 50 Day
  • ₹89.65
  • 100 Day
  • ₹91.59
  • 200 Day
  • ₹99.18

Resistance and Support

85.93 Pivot Speed
  • R3 90.26
  • R2 88.91
  • R1 87.28
  • S1 84.30
  • S2 82.95
  • S3 81.32

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Par Drugs and Chemicals has an operating revenue of Rs. 103.66 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of 17% is great, ROE of 11% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 50 which is a POOR score indicating inconsistency in earnings, a RS Rating of 33 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 67 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Par Drugs & Chemicals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-14 Audited Results & Others To consider other business matters
2026-02-10 Quarterly Results & Others To consider other business matters
2025-11-13 Quarterly Results & Others To consider other business matters
2025-08-29 Others To consider other business matters
2025-08-07 Quarterly Results & Others To consider other business matters

Par Drugs & Chemicals Shareholding Pattern

73.41%
0%
19.97%
6.62%

Par Drugs & Chemicals FAQs

Par Drugs & Chemicals share price is ₹87 As on 10 June, 2026 | 17:03

The Market Cap of Par Drugs & Chemicals is ₹108 Cr As on 10 June, 2026 | 17:03

The P/E ratio of Par Drugs & Chemicals is 8.2 As on 10 June, 2026 | 17:03

The PB ratio of Par Drugs & Chemicals is 1 As on 10 June, 2026 | 17:03

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23